• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺可视化激光消融术后的系列内镜检查

Serial endoscopy following visual laser ablation of prostate (VLAP).

作者信息

Marks L S

机构信息

Department of Surgery/Urology, UCLA School of Medicine.

出版信息

Urology. 1993 Jul;42(1):66-71. doi: 10.1016/0090-4295(93)90344-a.

DOI:10.1016/0090-4295(93)90344-a
PMID:7687080
Abstract

Visual laser ablation of the prostate (VLAP) was evaluated by serial video-endoscopy and six months of clinical correlation in 7 men suffering from advanced prostatism and urinary retention. Images of the prostatic urethra were obtained before and at various intervals from two to nineteen weeks after the procedure. A substantial tissue defect evolved within three months; complete healing required an even longer period. Except in the 1 patient with middle lobe obstruction, spontaneous urination was restored in all patients (including 2 cancer patients additionally treated with androgen deprivation). No operative complications were encountered. Thus, a safe and visually successful prostatectomy was the usual result of VLAP in the present patients. As a minimally invasive method to remove an obstructing prostate, laser treatment warrants further study.

摘要

通过连续视频内镜检查以及对7名患有晚期前列腺增生和尿潴留男性患者进行6个月的临床关联研究,对前列腺可视化激光消融术(VLAP)进行了评估。在手术前以及术后2至19周的不同时间间隔获取前列腺尿道图像。三个月内出现了明显的组织缺损;完全愈合需要更长时间。除1例中叶梗阻患者外,所有患者(包括另外接受雄激素剥夺治疗的2例癌症患者)均恢复了自主排尿。未出现手术并发症。因此,在本研究患者中,VLAP通常可实现安全且视觉上成功的前列腺切除术。作为一种去除梗阻性前列腺的微创方法,激光治疗值得进一步研究。

相似文献

1
Serial endoscopy following visual laser ablation of prostate (VLAP).前列腺可视化激光消融术后的系列内镜检查
Urology. 1993 Jul;42(1):66-71. doi: 10.1016/0090-4295(93)90344-a.
2
A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.经尿道前列腺切除术与可视化激光前列腺消融术治疗良性前列腺增生的前瞻性随机对照研究。
Urology. 1995 Aug;46(2):155-60. doi: 10.1016/s0090-4295(99)80185-x.
3
Holmium laser resection of the prostate versus neodymium:yttrium-aluminum-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy.钬激光前列腺切除术与钕:钇铝石榴石可视激光前列腺消融术:两种激光前列腺切除术技术的随机前瞻性比较
Urology. 1998 Apr;51(4):573-7. doi: 10.1016/s0090-4295(97)00642-0.
4
Visual laser ablation of the prostate (VLAP): an effective alternative treatment of benign prostatic hyperplasia.
Acta Urol Belg. 1995 Sep;63(3):45-9.
5
Visual laser ablation of the prostate: a preliminary report.前列腺的可视化激光消融:初步报告。
Mayo Clin Proc. 1995 Jan;70(1):28-32. doi: 10.1016/S0025-6196(11)64661-2.
6
Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate (VLAP) for the treatment of benign prostatic hyperplasia. 2-year follow-up.
Eur Urol. 2000 Sep;38(3):265-71. doi: 10.1159/000020292.
7
Visual laser ablation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia.经尿道前列腺激光剜除术与经尿道前列腺切除术治疗良性前列腺增生。
Int J Urol. 1996 Jan;3(1 Suppl):S55-9. doi: 10.1111/j.1442-2042.1996.tb00088.x.
8
Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.前列腺内镜激光消融术:治疗期间及治疗后的磁共振成像表现及其与临床结果的关系。
AJR Am J Roentgenol. 1995 Jun;164(6):1429-34. doi: 10.2214/ajr.164.6.7538727.
9
Visual laser ablation of the prostate (VLAP).
Can Oper Room Nurs J. 1995 Dec;13(4):6-9.
10
Outpatient visual laser-assisted prostatectomy under local anesthesia.局部麻醉下门诊可视激光辅助前列腺切除术
Urology. 1994 Feb;43(2):149-53. doi: 10.1016/0090-4295(94)90034-5.

引用本文的文献

1
Costs of minimally invasive laser surgery compared with transurethral electrocautery resection of the prostate.微创激光手术与经尿道前列腺电切术的成本比较。
West J Med. 1995 May;162(5):426-9.